RT Journal Article
SR Electronic
T1 Characterization of the genetic architecture of BMI in infancy and early childhood reveals age-specific effects and implicates pathways involved in Mendelian obesity
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.05.04.21256508
DO 10.1101/2021.05.04.21256508
A1 Øyvind Helgeland
A1 Marc Vaudel
A1 Pol Sole-Navais
A1 Christopher Flatley
A1 Julius Juodakis
A1 Jonas Bacelis
A1 Ingvild L. Koløen
A1 Gun Peggy Knudsen
A1 Bente B. Johansson
A1 Per Magnus
A1 Ted Reichborn Kjennerud
A1 Petur B. Juliusson
A1 Camilla Stoltenberg
A1 Oddgeir L. Holmen
A1 Ole A. Andreassen
A1 Bo Jacobsson
A1 Pål R. Njølstad
A1 Stefan Johansson
YR 2021
UL http://medrxiv.org/content/early/2021/05/07/2021.05.04.21256508.abstract
AB To elucidate the role of common genetic variation on infant and child weight development, we performed genome-wide association studies across 12 time points from birth to eight years in 28,681 children and their parents (27,088 mothers and 26,239 fathers) in the Norwegian Mother, Father and Child Cohort Study (MoBa). We identify 46 distinct loci associated with early childhood BMI at specific ages, matching different child growth phases, and representing four major trajectory patterns. Among these loci, 30 are independent of known birth weight and adult BMI loci, and 21 show peak effect between six months and three years, making these discoverable only at early age. Several of the 21 variants reside in/near genes previously implicated in severe forms of early-onset obesity, and monogenic obesity genes are enriched in the vicinity of the 46 loci. Four loci demonstrate evidence of several independent association signals as key drivers for BMI development near LEPR, GLP1R, PCSK1, and KLF14, all central to appetite and energy balance. At the KLF14 locus, we detect significant associations for maternally inherited alleles only, consistent with imprinting effects. Finally, we demonstrate how the BMI distribution stratified by different polygenic risk scores transitions from birth to adult profile throughout early childhood, and how age-specific polygenic risk scores improve the prediction of childhood obesity, outperforming scores based on adult BMI. In conclusion, our results offer a fine-grained characterization of the rapidly changing genetic association landscape sustaining early growth.Competing Interest StatementOAA is a consultant to HealthLytix. The other authors declare no competing interests.Funding StatementThis work was supported by grants (to S.J) Helse Vest's Open Research Grant (grants #912250 and F-12144), the Novo Nordisk Foundation (grant NNF19OC0057445) and the Research Council of Norway (grant #315599)); and (to P.R.N.) from the European Research Council (AdG SELECTionPREDISPOSED #293574), the Bergen Research Foundation ("Utilizing the Mother and Child Cohort and the Medical Birth Registry for Better Health"), Stiftelsen Kristian Gerhard Jebsen (Translational Medical Center), the University of Bergen, the Research Council of Norway (FRIPRO grant #240413), the Western Norway Regional Health Authority (Strategic Fund "Personalized Medicine for Children and Adults"), the Novo Nordisk Foundation (grant #54741), and the Norwegian Diabetes Association. This work was partly supported by the Research Council of Norway through its Centres of Excellence funding scheme (#262700, #223273), Better Health by Harvesting Biobanks (#229624) and The Swedish Research Council, Stockholm, Sweden (2015-02559), The Research Council of Norway, Oslo, Norway (FRIMEDBIO #547711, #273291), March of Dimes (#21-FY16-121). The Norwegian Mother, Father and Child Cohort Study is supported by the Norwegian Ministry of Health and Care Services and the Ministry of Education and Research, NIH/NIEHS (contract no N01-ES-75558), NIH/NINDS (grant no.1 UO1 NS 047537-01 and grant no.2 UO1 NS 047537-06A1). We are grateful to all the families in Norway who are taking part in this ongoing cohort study. All analyses were performed using digital labs in HUNT Cloud at the Norwegian University of Science and Technology, Trondheim, Norway.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The administrative board of the Norwegian Mother, Father and Child Cohort Study led by the Norwegian Institute of Public Health approved the study protocol. The establishment of MoBa and initial data collection was based on a license from the Norwegian Data Protection Agency and approval from The Regional Committee for Medical Research Ethics. The MoBa cohort is currently regulated by the Norwegian Health Registry Act. The study was approved by The Regional Committee for Medical Research Ethics (#2012/67).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSummary data from the discovery analysis will be made available for download at the Norwegian Mother, Father and Child Cohort Study website upon peer review. Access to genotypes and phenotypes can be obtained by direct request to the Norwegian Institute of Public Health. https://www.fhi.no/en/studies/moba https://www.fhi.no/en/studies/moba/for-forskere-artikler/gwas-data-from-moba